Alzheimer’s Disease Diagnostic Market Size Worth USD 7100 Million by 2030 at 8.90% CAGR – Report by Market Research Future (MRFR)

According to a Comprehensive Research Report by Market Research Future (MRFR), “Alzheimer’s Disease Diagnostic Market Information by Type, Diagnostic Test, End Users, and Region – Forecast till 2030”, Market is expected to reach USD 7,100 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030. 

Market Scope

Alzheimer’s Disease Diagnostic market refers to the market for medical devices and tools used to diagnose Alzheimer’s disease, which is a type of dementia that affects memory, thinking, and behavior. The market includes various diagnostic tests such as brain imaging, blood tests, and genetic testing.

The market for Alzheimer’s Disease Diagnostics is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of Alzheimer’s disease globally, rising geriatric population, and growing awareness about the importance of early diagnosis of the disease.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/2149

Report Scope:

Report AttributeDetails
Market Size in 2030USD 7,100 Million
CAGR 8.90%
Base Year2021
Forecast Period2022-2030
Historical Data2020
Forecast UnitsValue (USD Million)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredBy Type, Diagnostic Test and End User
Geographies CoveredNorth America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market DriversGrowth of chronic diseases worldwide like dementia
Technological advancement, macro economical and governing factors

Alzheimer’s Disease Diagnostic Market Competitive Landscape:

The affluent companies in the Alzheimer’s Disease Diagnostic industry include

  • Eli Lilly and Company
  • TauRx (Republic of Singapore)
  • Alector LLC
  • Accera, Inc
  • Treventis Corporation
  • Neuro-Bio Ltd
  • Cognition Therapeutics Inc
  • Hoffmann-La Roche
  • Novartis AG
  • Merck & Co
  • Pfizer Inc
  • Allergan PLC
  • Daiichi Sankyo Co

June 2022

Diadem SpA announced the development of AlzoSure Predict, which is a first-of-its-kind, non-invasive blood test to predict the early onset of Alzheimer’s disease (AD). The company has partnered with Dementias Platform UK to advance its efforts.

June 2022

SYNAPS Dx (SDx) announced its focus on research and development in the area of neurological disorder diagnostics, including Alzheimer’s disease. The company is also working towards commercialization and uses Alzheimer’s & Brain Awareness Month in June to raise awareness of brain disorders and Alzheimer’s disease as significant health concern for the public.

Alzheimer’s Disease Diagnostic Market Trends:

Market Drivers:

One major driver in the Alzheimer’s Disease Diagnostic market is the increasing prevalence of Alzheimer’s disease globally. As the population ages, the incidence and prevalence of Alzheimer’s disease are expected to rise, creating a greater demand for accurate and reliable diagnostic tools. Alzheimer’s disease is a neurodegenerative disorder that causes a progressive decline in cognitive function, including memory loss, language difficulties, and impaired judgment. It is the most common cause of dementia in older adults, and the number of people living with Alzheimer’s disease is projected to increase significantly in the coming years. The growing prevalence of Alzheimer’s disease has led to a growing demand for diagnostic tools that can accurately detect the disease in its early stages. Early diagnosis is critical for effective management of the disease and can help improve patient outcomes. As a result, there is an increasing need for reliable and accurate diagnostic tools that can help identify Alzheimer’s disease early on.

Discover more research Reports on Healthcare Industry by Market Research Future:

DNA Sequencing Market Research Report Information By Product (Consumable, Instrument, and Service), By Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, and Forensics), By Technology (Semiconductor Sequencing, Sequencing by Ligation, and Pyrosequencing), By End-User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Genetic Testing Market Size amd Trends Analysis By Type (Prescribed Genetic Testing and Direct-to-Consumer Genetic Testing), Method (Molecular Genetic Tests/ DNA Tests, Chromosomal Genetic Tests and Biochemical Genetic Tests), By Application (Reproductive Health (Newborn Screening, Prenatal Screening and Carrier Screening), Cancer Screening (Hereditary Cancer, Breast Cancer, Ovarian Cancer and Colon Cancer), Ancestry, Predictive and Pre-Symptomatic Testing and others) – Forecast till 2030

Cancer Diagnostics Market Size, Trends and Industry Outlook by Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer and others), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2030

    Written by

    Market Research Future

    Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis regarding diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

    Leave a Comment